Early outcomes from the pivotal trial of a four-branch off-the shelf solution to treat complex abdominal and type IV thoracoabdominal aortic aneurysms

Mark A. Farber,Jon S. Matsumura,Sukgu Han,Michel S. Makaroun,Bjoern D. Suckow,Carlos H. Timaran,Bernardo C. Mendes,Gustavo S. Oderich
DOI: https://doi.org/10.1016/j.jvs.2024.05.020
IF: 4.86
2024-06-22
Journal of Vascular Surgery
Abstract:CONCLUSIONS: Early TAMBE device outcomes demonstrate a high technical success rate, no 30-day lesion-related mortality, and a low rate of safety events within 30 days of the index procedure.
surgery,peripheral vascular disease
What problem does this paper attempt to address?